Showing results (21-30 of 93) with videos related to
Sort By:
Pageof 10
Journal of Medicinal Chemistry|June 28, 2014
Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship studyStephanie Federico, Antonella Ciancetta, Nicola Porta, et al.European Journal of Medicinal Chemistry|November 6, 2013
8-(2-Furyl)adenine derivatives as A₂A adenosine receptor ligandsDiego Dal Ben, Michela Buccioni, Catia Lambertucci, et al.Journal of Chemical Information and Modeling|January 25, 2008
Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptorLisa Michielan, Magdalena Bacilieri, Andrea Schiesaro, et al.Expert Opinion on Therapeutic Patents|March 23, 2012
Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligandsStephanie Federico, Giampiero SpallutoMolecular Pharmaceutics|February 2, 2012
A novel conjugated agent between dopamine and an A2A adenosine receptor antagonist as a potential anti-Parkinson multitarget approachAlessandro Dalpiaz, Barbara Cacciari, Chiara Beatrice Vicentini, et al.Journal of Medicinal Chemistry|January 7, 2005
Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key studyStefano Moro, Paolo Braiuca, Francesca Deflorian, et al.Current Pharmaceutical Design|October 9, 2002
Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: a possible template for adenosine receptor subtypes?Pier Giovanni Baraldi, Barbara Cacciari, Pier Andrea Borean, et al.Journal of Medicinal Chemistry|March 3, 2006
Synthesis and biological studies of a new series of 5-heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists. Influence of the heteroaryl substituent on binding affinity and molecular modeling investigationsGiorgia Pastorin, Tatiana Da Ros, Chiara Bolcato, et al.Journal of Medicinal Chemistry|September 19, 2003
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigationGiorgia Pastorin, Tatiana Da Ros, Giampiero Spalluto, et al.Journal of Medicinal Chemistry|February 8, 2002
Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonistsPier Giovanni Baraldi, Barbara Cacciari, Stefano Moro, et al.Pageof 10